Feed Preview

Neurohumoral Compensatory Mechanisms

Neurohumoral Compensatory Mechanisms diagram by ellepigrafica, Shutterstock
ellepigrafica, Shutterstock

The activation of neurohumoral compensatory mechanisms is a common physiological phenomenon in heart failure in order to make up for a failing heart, which will usually have a deteriorating effect on overall health condition. Discover the latest research on Neurohumoral Compensatory Mechanisms here.

Top 20 most recent papers
European Heart Journal

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

European Heart JournalMarch 30, 2020
Kieran F DochertyJohn J V McMurray
47
3
European Journal of Heart Failure

Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF

European Journal of Heart FailureMarch 28, 2020
Ify R MordiChim C Lang
Clinical Research in Cardiology : Official Journal of the German Cardiac Society

Covariate adjusted reanalysis of the I-Preserve trial

Clinical Research in Cardiology : Official Journal of the German Cardiac SocietyMarch 28, 2020
João Pedro FerreiraJohn J V McMurray
JCI Insight

Cardiovascular response to small molecule APJ activation

JCI InsightMarch 26, 2020
Brandon AsonAarif Khakoo
Journal of the American College of Cardiology

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

Journal of the American College of CardiologyMarch 21, 2020
Julio A ChirinosThomas P Cappola
31
Journal of the American College of Cardiology

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan

Journal of the American College of CardiologyMarch 21, 2020
Senthil SelvarajScott D Solomon
4
2
Frontiers in Physiology

The Effect of Carotid Chemoreceptor Inhibition on Exercise Tolerance in Chronic Heart Failure

Frontiers in PhysiologyApril 1, 2020
Sophie É CollinsMichael K Stickland
The New England Journal of Medicine

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

The New England Journal of MedicineMarch 19, 2020
Arno A van de BovenkampM Louis Handoko
The American Journal of Medicine

Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials

The American Journal of MedicineMarch 17, 2020
Morten Rix HansenJesper Hallas
3
International Journal of Biological Sciences

TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway

International Journal of Biological SciencesMarch 27, 2020
Sen GuoLuosha Zhao
The New England Journal of Medicine

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

The New England Journal of MedicineMarch 19, 2020
Babak YazdaniBernhard K Krämer

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/neurohumoral-compensatory-mechanisms/d1d63849-0651-4e13-96af-91a8aaae1728